Exact Sciences Corp.(NASDAQ: EXAS) today announced that a new peer-reviewed study of Cologuard®, a multi-target stool DNA test (MT-sDNA), confirms ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE